ADGM — Adagio Medical Holdings Cashflow Statement
0.000.00%
- $21.18m
- $37.70m
- $0.60m
Annual cashflow statement for Adagio Medical Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -19.9 | -23.7 | -36.6 | -75 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | -0.284 | 0.436 | 7.62 | 40.3 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.579 | 0.33 | 2.79 | 5.79 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -19.3 | -22.4 | -25.7 | -29.5 |
| Capital Expenditures | -1.27 | -0.502 | -0.34 | -1.65 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | — | 0.002 | 0 | — |
| Sale of Fixed Assets | ||||
| Cash from Investing Activities | -1.27 | -0.5 | -0.34 | -1.65 |
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.13 | 9.53 | 21.9 | 15.6 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -20.4 | -13.3 | -4.16 | -15.3 |